C369-0457 Screening compound: N-[2-(4-benzylpiperazin-1-yl)ethyl]-7-methoxyfuro[2,3-b]quinoline-2-carboxamide

C369-0457 Screening compound: N-[2-(4-benzylpiperazin-1-yl)ethyl]-7-methoxyfuro[2,3-b]quinoline-2-carboxamide
C369-0457 Screening compound: N-[2-(4-benzylpiperazin-1-yl)ethyl]-7-methoxyfuro[2,3-b]quinoline-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C369-0457
N-[2-(4-benzylpiperazin-1-yl)ethyl]-7-methoxyfuro[2,3-b]quinoline-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C369-0457

Molecular Formula

C26H28N4O3 (C26 H28 N4 O3)

Compound Name

N-[2-(4-benzylpiperazin-1-yl)ethyl]-7-methoxyfuro[2,3-b]quinoline-2-carboxamide

IUPAC name

N-[2-(4-benzylpiperazin-1-yl)ethyl]-7-methoxyfuro[23-b]quinoline-2-carboxamide

SMILES

COc1ccc(cc(cc(C(NCCN2CCN(Cc3ccccc3)CC2)=O)o2)c2n2)c2c1

InChI

InChI=1S/C26H28N4O3/c1-32-22-8-7-20-15-21-16-24(33-26(21)28-23(20)17-22)25(31)27-9-10-29-11-13-30(14-12-29)18-19-5-3-2-4-6-19/h2-8,15-17H,9-14,18H2,1H3,(H,27,31)

InChI Key

ZYXWNMJZDMHGDT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14753990

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

444.53

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.379

Distribution Coefficient, logD

3.240

Water Solubility, LogSw

-3.91

Polar Surface Area

56.357

Acid Dissociation Constant (pKa)

12.37

Base Dissociation Constant (pKb)

6.97

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.80

C369-0457 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Human Transcription Factors Annotated Library (5098 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • Epigenetic

References: we are preparing a list of scientific research reports with C369-0457 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C369-0457?
Check Price and Availability of C369-0457, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C369-0457 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C369-0457
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C369-0457
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C369-0457 available by request